Effect of high-efficiency particulate air filter on children with asthma: a systematic review protocol of RCTs Authors: Javeria Mansoor, Muhammad Zia Ul Haq, Zeeshan Ahsan, Muhammad Bilal, Syeda Sadia Fatima Published: 2024 ABSTRACT AbstractIntroductionAsthma has been classified as a major non-communicable disease by the WHO. With the worsening air quality index worldwide, the burden of asthma has increased specifically in children. The focus of the management strategy of asthma has shifted from traditional pharmacological treatments towards non-pharmacological preventive and control therapy in recent decades. The use of high-efficiency particulate air (HEPA) filters is one of the methods to achieve that, despite extensive research, the efficacy of HEPA filters in this context of effectiveness and usage guidelines remains unclear. Our study aims to examine the effect of HEPA filters in (1) reducing clinical visits or hospital admissions or the number of exacerbation events, (2) reducing asthma symptoms, (3) increasing asthma symptom-free days, (4) reducing indoor particulate matter 2.5 levels for children with asthma aged 5–17 years and (5) improving quality of life.MethodsWe will conduct a systematic review using MEDLINE, Google Scholar and Scopus as databases, article selection is planned to be restricted to randomised controlled trials only (2002–2025). We are following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines developed specifically for the protocol(s). Two reviewers will screen the studies independently and assess study quality using the Cochrane Risk of Bias Tool for Randomised Trials, V.2. The results of outcome measure(s) will be summarised in tables. If the studies are sufficient, we will also perform a quantitative analysis by creating forest plots and subgroup analysis will be performed if required. Lastly, publication bias will be assessed using a funnel plot and Egger’s test and reported accordingly.Ethics and disseminationWe will conduct a systematic review, therefore there is no need for a formal ethical review. After successful completion, our results will be published in a peer-reviewed journal.PROSPERO registration numberCR42024494949. STRENGTHS AND LIMITATIONS OF THIS STUDY The inclusion of recent evidence will provide a contemporary perspective on the efficacy of high-efficiency particulate air (HEPA) filters in paediatric asthma management. The inclusion of recent evidence will provide a contemporary perspective on the efficacy of high-efficiency particulate air (HEPA) filters in paediatric asthma management. Two independent reviewers will screen the articles according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to minimise potential personal biases. Two independent reviewers will screen the articles according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to minimise potential personal biases. The systematic review will extend to meta-analysis with subgroup analysis to identify how each subgroup responds to the intervention. The systematic review will extend to meta-analysis with subgroup analysis to identify how each subgroup responds to the intervention. The review could face heterogeneity due to differences in populations, regions and air quality and variation in the design and performance of HEPA filters across manufacturers across included studies. The review could face heterogeneity due to differences in populations, regions and air quality and variation in the design and performance of HEPA filters across manufacturers across included studies. Potential language or publication bias may arise from only including studies from certain regions or journals. Potential language or publication bias may arise from only including studies from certain regions or journals. Introduction Asthma and air pollution Out of the total paediatric population in the USA, approximately 4.7 million were living with asthma in 2021.1 Children belonging to the adolescent age group between 10 and 17 years (10.4%) had the highest prevalence of asthma, followed by the group of 5–9 years children (9.5%) and it was lowest among children<5 years of age (5.3%) in the last two decades, as report by CDC (Centers for Disease Control and Prevention).2 Severe asthma symptoms disproportionately affect children in low- and middle-income countries where the WHO highlights treatment access as a major challenge contributing to higher asthma-related mortality.3 4 These adverse outcomes on child health are a result of a substantial global threat which is air pollution.5 There are various harmful constituents of air pollution which are broadly classified based on aerodynamic diameter (particulate matter (PM)10 and PM2.5) in literature and it is established that among the most threatening to human health are the ones which are less than 2.5 μm in size.6 It has the potential to impact human health as it is absorbed through the respiratory tract and infiltrates the lung alveoli.7 Indoor air pollution is a greater threat as compared with outdoor and its control is recommended to be a key component for the management of asthma. This indoor air pollution is a complex mixture of both agents coming from ambient air and produced by indoor sources which include products of combustion, nitrogen oxides, allergens and other PM constituents which become part of the home environment of children specifically. Exposure to these pollutants not only results in increased symptoms of cough and wheezing but also exacerbation asthma resulting in high hospitalisation rates.8 Use of air filters High-efficiency particulate air (HEPA) filters, capable of removing over 99.97% of airborne particles larger than 0.3 μm, including common asthma triggers like dust and pollen, are recommended for improving indoor air quality.9 This filter works by five mechanisms which include interception, sieve effect, lodgement, Brownian diffusion and static charge effect as well.10 Therefore, they can reduce PM2.5 levels and in turn, benefit asthmatic children.11 The use of HEPA filters is reported suitable for domestic use as they are available in portable forms12 and particularly beneficial for families with young children.13 Recent advancements leading to the incorporation of internet of things based innovations to these filters can make them a device of real-time air quality monitoring, which can make people alert to take action.14 Therefore, they have the potential to be used for both closed-space environmental monitoring and as a tool for reducing transmission risks of micro-organisms including viruses in homes and even in places like child daycare centres.15 Addressing the environmental triggers through non-pharmacological interventions, including air filtration, becomes essential. Apart from usual pharmacological management, patient education and control of triggering factors are crucial to asthma control.16 Thus, low air quality which has a significant impact on worsening conditions in asthmatic children should be reduced or ideally eliminated.17 Schuers et al showed that multifaceted interventions which combined patient education with exposure reduction and renovating indoor spaces significantly improved clinically relevant outcomes of asthma.18 Parents as caregivers of asthmatic children were found to be proactive and interested in implementing preventative behaviours besides traditional therapy in a qualitative study.19 Financial and economic impact linked to asthma burden is significant and this preventive measure has shown cost-effectiveness in a study by Wu and Takaro.20 They are reported to cost relatively less than other air cleaning technologies as it is low maintenance that is they require to be serviced only once annually.21 Research gap Prior systematic reviews have broadly evaluated air filtration systems but lacked a focused examination of the paediatric population22 or the exclusive use of HEPA filters.17 A systematic review published in 2002 summarised the outcomes on patients with asthma in the form of mean difference in total symptoms by using residential air filter systems.23 However, it was not specifically focused on HEPA filters and included both adults and children and in the last 20 years, various advancements in the technology of air filters have been made including the addition of more antibacterial properties and the use of better raw material(s) in the manufacturing process.24 Therefore, it is important to generate new evidence in this regard. This review aims to fill that gap, providing insights into the utility of HEPA filters in improving asthma symptoms and also in decreasing its triggering factors in home or school settings, thereby informing future interventions tailored for children with asthma. By concentrating on HEPA filters, this review seeks to offer conclusive evidence supporting their role in asthma management, highlighting the necessity of integrating effective environmental control measures within asthma care strategies. Aim The systematic review aims to investigate the effectiveness of HEPA filters in either increasing the number of asthma symptom(s) free days or reducing asthma symptoms, hospitalisation rates or exacerbation events in children aged 5–17 years and additionally reducing indoor PM 2.5 levels. Objective(s) To systematically review the evidence of randomised controlled trials (RCTs) which evaluate the effectiveness of HEPA filtration systems for asthmatic children in (1) reduction in a number of clinical visits or hospital admissions or exacerbation events, (2) reduction in asthma symptoms, (3) increase in asthma symptom-free days, (4) reduction in indoor PM2.5 levels and (5) quality of life. Methods Registration and guideline This protocol is registered with the PROSPERO database (CR42024494949), adhering to the Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) guidelines for systematic review protocols to ensure transparency and methodological rigour.25 The PRISMA-P checklist is included as online supplemental file 2. The selection criteria based on the PICO framework are presented in table 1. Table 1The selection criteriaCharacteristicInclusionExclusionParticipantsChildren aged 5–17 years.Diagnosed with asthma.With or without secondhand smoke exposure.Studies in which participants are children and mother pair or pregnant women.InterventionHEPA filter solely as an intervention in at least one of the groups.Studies in which type of air cleaning filter is not specified.ComparatorNo intervention.Placebo (including inactive air filters).Different types of air filters other than HEPA.Comparison with adult patients with asthma.OutcomesMain outcome:Reduced number of clinical visits or hospital admissions.Additional Outcomes:Reduction in asthma symptoms.Increase in the number of asthma symptom-free days.Reduced the number of exacerbation events.Improved quality of life.Reduction in indoor PM2.5 levels.Studies in which data could not be extracted.Study characteristicsOnly original randomised control trials (RCT).Studies published in the English language.Studies conducted in or after 2002.Studies from journals which are from peer-reviewed journals.Setting can be both home or school.From low, middle and high-income countries.Review articles.Conducted before 2002.HEPAHigh-Efficiency Particulate AirPMParticulate Matter The selection criteria HEPAHigh-Efficiency Particulate AirPMParticulate Matter Databases Electronic databases such as MEDLINE, Google Scholar and Scopus will be thoroughly searched for eligible articles initially, then we will also use Google Scholar to manually search the references of the included studies and track their citations in order to find more relevant studies. We do not plan to include any grey literature. Search strategy Our search strategy will be based on four concepts, main target disease (‘Asthma’), intervention, (‘HEPA filter’) and population characteristics, included with synonyms (‘Children’ OR ‘Pediatric population’) and lastly, the study design (‘Randomized controlled trial’). A university librarian is taken on board to improvise the strategy as well. The detailed search strategy is provided in the online supplemental material. Search dates We plan to initiate our search from the year 2002 till 2025 by using a time filter within the databases. The anticipated start date of the review will be 1st January 2025 and we aim to conclude the review by 1st August 2025. Selection of studies We will use EndNote X.9 to import and manage articles, systematically removing duplicates to streamline the review process. Two independent reviewers will initially screen the articles based on titles and then screen the articles shortlisted based on abstracts subsequently, potential studies will undergo a full-text review to determine final inclusion against our predefined selection criteria (table 1), any contradictions will be initially attempted to get resolved by discussion and mutual agreement if in case further resolution is required a senior third reviewer will be consulted. At the end of the study selection process, a PRISMA flow diagram will be constructed and reported. Data extraction Data from the included studies will be systematically extracted using a standardised form in an MS Excel sheet. The extracted data will include study characteristics such as title, authors, year of publication, country and journal. Population characteristics will capture details such as age, gender distribution, comorbidities and sample size. Information on the intervention and control will cover the type of HEPA filter used, the control group description and the intervention duration. Outcome measures will include both primary and secondary outcomes, such as asthma symptom improvement, quality of life, lung function and adverse effects. Additional details will include the type of RCT, randomisation methods, blinding, follow-up period and study setting (e.g, home or school). Main findings, including statistical significance, will also be extracted. Assessment of quality Cochrane Risk of Bias Tool for Randomised Trials, V.2 will be used for assessment based on which studies will be classified as unclear, low or high risk of bias. Additionally, the Grading of Recommendations Assessment, Development and Evaluation assessment framework might be used further to assess the quality of studies in case meta-analysis is feasible. Data synthesis and analysis Findings will be summarised in the form of a table for qualitative synthesis. If possible, a meta-analysis will be performed. Heterogeneity within the included studies will be quantified by calculating the I² statistic which is a heterogeneity measure used to estimate the variability in a meta-analysis explained by differences in the included trial. Our results will be considered sufficiently homogeneous, if I² statistic is below 50%. A sensitivity analysis will be done to assess the robustness of the findings. Lastly, a funnel plot will be created and Egger’s test will be used for the assessment of publication bias. RevMan V.5.4 will be used for data analysis. Subgroup analysis If required, subgroup analysis will involve potential sources of heterogeneity among the included studies and participants which may include variations in asthma severity, geographical location or air quality index, duration of HEPA filter use and narrower age ranges within the 5–17 category. Stratified analyses will be conducted within each subgroup, allowing us to discern potential patterns and interactions. Patient and public involvement Patient and public were not involved in the design, conduct or dissemination plan of this study. Amendments Any deviation from the methodology described in this protocol will be recorded during each step of the screening data synthesis and data analysis process and will be reported accordingly during final reporting. Strengths and limitations Our review distinguishes itself by specifically evaluating the effectiveness of HEPA filters, a less explored area in paediatric asthma management. This is going to be a review of only RCT experimental studies with recent evidence of knowledge. There is the possibility of variation in studies due to different countries, populations, manufacturers of HEPA filters and air quality of respective areas/regions. Ethics and dissemination This review will solely consider published literature and all data derived from the incorporated studies will be already anonymous and derives from publically available databases. Therefore, formal ethical clearance is not required. Our findings will give comprehensive evidence of the use of HEPA filters for children diagnosed with asthma. We will disseminate the final review in academic journals that adhere to a peer-review process. supplementary material